Purpose: This study aimed to examine the association between alcohol consumption and the risk of major adverse cardiovascular events (MACE) among Taiwanese adults.
Methods: This prospective cohort study was conducted in northern Taiwan, including 5,145 participants. Data were collected through questionnaires covering socio-economic status, medical history, medication use, and lifestyle factors. MACE, the primary endpoint, was identified using ICD-9 and ICD-10 diagnostic codes. Hazard ratios (HR) and 95% confidence intervals (CI) for each alcohol consumption category were estimated using a Cox proportional hazards model, adjusted for age, body mass index (BMI), smoking status, and diabetes history.
Results: A total of 2,167 males and 2,978 females participated. Among males, the hazard ratio for MACE increased progressively with higher weekly alcohol consumption, reaching statistical significance at a cut-off of 420g (HR=1.657, p=0.034). In light drinkers, the HR was below 1, suggesting a potential protective effect, although not statistically significant. Among females, the HR for MACE also increased with higher alcohol consumption, but it did not reach statistical significance. In light drinkers, the HR remained above 1, indicating an increased risk, though this was not statistically significant.
Conclusion: After adjusting for age, BMI, smoking status, and diabetes history, alcohol consumption was found to be a significant risk factor for MACE, particularly in males. A J-shaped relationship was observed in males, where weekly alcohol consumption exceeding 420g was associated with a significantly higher risk of MACE compared to non-drinkers. In females, while alcohol consumption appeared to increase the risk of MACE, the association did not reach statistical significance. These findings suggest that the relationship between alcohol consumption and cardiovascular risk may differ between genders, warranting further investigation to better understand these differential effects and inform public health strategies aimed at reducing alcohol-related cardiovascular risk.